Complex Issues of Cardiovascular Diseases,
Journal Year:
2023,
Volume and Issue:
12(4S), P. 162 - 172
Published: Dec. 29, 2023
Highlights
The
review
presents
up-to-date
data
on
the
contribution
of
type
2
diabetes
mellitus
to
development
and
progression
heart
failure.
highlights
key
mechanisms
pathogenesis
failure
associated
with
changes
in
energy
metabolism
cardiomyocytes.
Abstract
Type
is
one
main
risk
factors
that
significantly
worsen
prognosis
increases
probability
fatal
cardiovascular
events.
diabetic
patients
involves
a
great
number
for
rapid
atherosclerosis,
as
well
numerous
combinations
neurohumoral,
molecular
histological
not
atherogenesis,
which
interconnection
results
complications
decompensation.
This
discusses
underlying
mellitus,
particular,
special
attention
paid
cardiomyocyte
metabolism,
death,
significance
epigenetic
chronic
Frontiers in Medicine,
Journal Year:
2021,
Volume and Issue:
8
Published: June 30, 2021
Individuals
with
diabetes
mellitus
(DM)
disclose
a
higher
incidence
and
poorer
prognosis
of
heart
failure
(HF)
than
non-diabetic
people,
even
in
the
absence
other
HF
risk
factors.
The
adverse
impact
on
likely
reflects
an
underlying
"diabetic
cardiomyopathy"
(DM-CMP),
which
may
by
exacerbated
left
ventricular
hypertrophy
coronary
artery
disease
(CAD).
pathogenesis
DM-CMP
has
been
hot
topic
research
since
its
first
description
is
still
under
active
investigation,
as
complex
interplay
among
multiple
mechanisms
play
role
at
systemic,
myocardial,
cellular/molecular
levels.
Among
these,
metabolic
abnormalities
such
lipotoxicity
glucotoxicity,
mitochondrial
damage
dysfunction,
oxidative
stress,
abnormal
calcium
signaling,
inflammation,
epigenetic
factors,
others.
These
disturbances
predispose
diabetic
to
extracellular
remodeling
hypertrophy,
thus
leading
diastolic
systolic
dysfunction.
This
Review
aims
outline
major
pathophysiological
changes
myocardial
cardiac
functional
derangement
DM-CMP.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Aug. 5, 2024
Protein
post-translational
modification
(PTM)
is
a
covalent
process
that
occurs
in
proteins
during
or
after
translation
through
the
addition
removal
of
one
more
functional
groups,
and
has
profound
effect
on
protein
function.
Glycosylation
most
common
PTMs,
which
polysaccharides
are
transferred
to
specific
amino
acid
residues
by
glycosyltransferases.
A
growing
body
evidence
suggests
glycosylation
essential
for
unfolding
various
activities
organisms,
such
as
playing
key
role
regulation
function,
cell
adhesion
immune
escape.
Aberrant
also
closely
associated
with
development
diseases.
Abnormal
patterns
linked
emergence
health
conditions,
including
cancer,
inflammation,
autoimmune
disorders,
several
other
However,
underlying
composition
structure
glycosylated
have
not
been
determined.
It
imperative
fully
understand
internal
differential
expression
glycosylation,
incorporate
advanced
detection
technologies
keep
knowledge
advancing.
Investigations
clinical
applications
focused
sensitive
promising
biomarkers,
effective
small
molecule
targeted
drugs
emerging
vaccines.
These
studies
provide
new
area
novel
therapeutic
strategies
based
glycosylation.
European Journal of Heart Failure,
Journal Year:
2023,
Volume and Issue:
25(8), P. 1199 - 1212
Published: July 12, 2023
The
development
of
the
foetal
heart
is
driven
by
increased
glucose
uptake
and
activation
mammalian
target
rapamycin
(mTOR)
hypoxia-inducible
factor-1α
(HIF-1α),
which
drives
glycolysis.
In
contrast,
healthy
adult
governed
sirtuin-1
(SIRT1)
adenosine
monophosphate-activated
protein
kinase
(AMPK),
promote
fatty-acid
oxidation
substantial
mitochondrial
ATP
production
required
for
survival
in
a
high-workload
normoxic
environment.
During
cardiac
injury,
recapitulates
signalling
programme,
(although
adaptive
short
term)
highly
deleterious
if
sustained
long
periods
time.
Prolonged
increases
cardiomyocytes
under
stress
leads
to
flux
through
hexosamine
biosynthesis
pathway;
its
endproduct
-
uridine
diphosphate
N-acetylglucosamine
(UDP-GlcNAc)
functions
as
critical
nutrient
surplus
sensor.
UDP-GlcNAc
post-translational
modification
known
O-GlcNAcylation,
rapidly
reversibly
modifies
thousands
intracellular
proteins.
Both
O-GlcNAcylation
phosphorylation
act
at
serine/threonine
residues,
but
whereas
regulated
hundreds
specific
kinases
phosphatases,
only
two
enzymes,
O-GlcNAc
transferase
(OGT)
O-GlcNAcase
(OGA),
adds
or
removes
GlcNAc
(N-acetylglucosamine),
respectively,
from
Recapitulation
programming
failure
(regardless
diabetes)
accompanied
marked
both
experimentally
clinically.
Heightened
impaired
calcium
kinetics
contractile
derangements,
arrhythmias
related
voltage-gated
sodium
channels
Ca2+
/calmodulin-dependent
II,
dysfunction,
maladaptive
hypertrophy,
microvascular
fibrosis
cardiomyopathy.
These
effects
can
be
prevented
suppression
achieved
upregulation
AMPK
SIRT1
pharmacological
inhibition
OGT
stimulation
OGA.
sodium-glucose
cotransporter
2
(SGLT2)
inhibitors
on
are
reduced
their
cytoprotective
reportedly
abrogated
action
suppress
blocked.
Such
an
may
represent
one
many
mechanisms
enhanced
following
SGLT2
cardiovascular
benefits.
observations,
taken
collectively,
suggest
that
sensor
(which
acting
concert
with
mTOR
HIF-1α)
Cell Death Discovery,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: July 28, 2023
Abstract
Cardiovascular
diseases
(CVDs)
such
as
atherosclerosis,
myocardial
remodeling,
ischemia-reperfusion
(I/R)
injury,
heart
failure,
and
oxidative
stress
are
among
the
greatest
threats
to
human
health
worldwide.
pathogenesis
has
been
studied
for
decades,
influence
of
epigenetic
changes
on
CVDs
extensively
studied.
Post-translational
modifications
(PTMs),
including
phosphorylation,
glycosylation,
methylation,
acetylation,
ubiquitination,
ubiquitin-like
nitrification,
play
important
roles
in
normal
functioning
cardiovascular
system.
Over
past
decade,
with
application
high-performance
liquid
chromatography-tandem
mass
spectrometry
(HPLC-MS/MS),
an
increasing
number
novel
acylation
have
discovered,
propionylation,
crotonylation,
butyrylation,
succinylation,
lactylation,
isonicotinylation.
Each
change
protein
conformation
potential
alter
function
lead
CVDs,
this
process
is
usually
reversible.
This
article
summarizes
mechanisms
underlying
several
common
PTMs
involved
occurrence
development
CVDs.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(5), P. 571 - 571
Published: May 6, 2024
Protein
posttranslational
modifications
are
important
factors
that
mediate
the
fine
regulation
of
signaling
molecules.
O-linked
β-N-acetylglucosamine-modification
(O-GlcNAcylation)
is
a
monosaccharide
modification
on
N-acetylglucosamine
linked
to
hydroxyl
terminus
serine
and
threonine
proteins.
O-GlcNAcylation
responsive
cellular
stress
as
reversible
nuclear,
mitochondrial
cytoplasmic
Mitochondrial
proteins
main
targets
key
regulator
homeostasis
by
directly
regulating
proteome
or
protein
activity
function.
Disruption
closely
related
dysfunction.
More
importantly,
cardiac
has
been
proven
be
protective
harmful
crucial
for
contractile
function
myocardial
cell
metabolism,
imbalance
plays
role
in
pathogenesis
cardiovascular
diseases
(CVDs).
In
this
review,
we
will
focus
interactions
between
provide
insights
CVDs.
Journal of Biological Chemistry,
Journal Year:
2023,
Volume and Issue:
300(2), P. 105616 - 105616
Published: Dec. 29, 2023
O-linked
β-N-acetylglucosamine
(O-GlcNAcylation)
is
a
dynamic
post-translational
modification
that
regulates
thousands
of
proteins
and
almost
all
cellular
processes.
Aberrant
O-GlcNAcylation
has
been
associated
with
numerous
diseases,
including
cancer,
neurodegenerative
cardiovascular
type
2
diabetes.
highly
nutrient-sensitive
since
it
dependent
on
UDP-GlcNAc,
the
end
product
hexosamine
biosynthetic
pathway
(HBP).
We
previously
observed
daily
rhythmicity
protein
in
Drosophila
model
sensitive
to
timing
food
consumption.
showed
circadian
clock
pivotal
regulating
rhythms
given
its
control
feeding-fasting
cycle
hence
nutrient
availability.
Interestingly,
we
reported
also
modulates
rhythm
by
molecular
mechanisms
beyond
regulation
consumption
time.
A
large
body
work
now
indicates
likely
generalized
status
effector
as
responds
various
signals
conditions,
such
ER
stress,
apoptosis,
infection.
In
this
review,
summarize
metabolic
through
availability,
HBP
enzymes,
O-GlcNAc
processing
enzymes.
discuss
emerging
roles
clocks
rhythm.
Finally,
provide
an
overview
other
or
conditions
impact
O-GlcNAcylation.
Many
these
pathways
are
themselves
regulated
and/or
metabolism.
Our
review
highlights
importance
maintaining
optimal
restricting
eating
activity
active
period
under
physiological
provides
insights
into
potential
therapeutic
targets
homeostasis
pathological
conditions.
Journal of Cardiovascular Translational Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 3, 2025
Post-translational
modifications
(PTMs),
which
are
covalent
alterations
of
proteins
after
their
synthesis,
critical
for
proper
function
and
the
maintenance
cellular
physiology.
The
significance
PTMs
in
context
cardiovascular
diseases
(CVDs)
has
been
increasingly
recognized
due
to
potential
influence
protein
stability,
activity,
localization,
thereby
affecting
progression
CVDs.
identification
understanding
CVDs
at
molecular
level
vital
discovery
new
biomarkers
targets
clinical
interventions.
This
article
provides
a
comprehensive
overview
role
mechanisms
types
PTMs,
such
as
acetylation,
crotonylation,
succinylation,
S-nitrosylation,
malonylation,
S-palmitonylation,
β-hydroxybutyrylation
lactylation,
CVDs,
highlighting
importance
advancing
diagnostic
therapeutic
approaches
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 24, 2022
The
heart
is
a
highly
metabolic
organ
with
extensive
energy
demands
and
hence
relies
on
numerous
fuel
substrates
including
fatty
acids
glucose.
However,
oxidative
stress
natural
by-product
of
metabolism
that,
in
excess,
can
contribute
towards
DNA
damage
poly-ADP-ribose
polymerase
activation.
This
activation
inhibits
key
glycolytic
enzymes,
subsequently
shunting
intermediates
into
non-oxidative
glucose
pathways
such
as
the
hexosamine
biosynthetic
pathway
(HBP).
In
this
review
we
provide
evidence
supporting
dual
role
HBP,
i.e.
playing
unique
cardiac
physiology
pathophysiology
where
acute
upregulation
confers
cardioprotection
while
chronic
contributes
to
onset
progression
cardio-metabolic
diseases
diabetes,
hypertrophy,
ischemic
disease,
failure.
Thus
although
HBP
has
emerged
novel
therapeutic
target
for
conditions,
proposed
interventions
need
be
applied
context-
pathology-specific
manner
avoid
any
potential
drawbacks
relatively
low
activity.
Cell Stress and Chaperones,
Journal Year:
2023,
Volume and Issue:
28(6), P. 641 - 655
Published: July 5, 2023
Diabetic
cardiomyopathy
describes
decreased
myocardial
function
in
diabetic
patients
the
absence
of
other
heart
diseases
such
as
ischemia
and
hypertension.
Recent
studies
have
defined
numerous
molecular
interactions
signaling
events
that
may
account
for
deleterious
changes
mitochondrial
dynamics
functions
influenced
by
hyperglycemic
stress.
A
metabolic
switch
from
glucose
to
fatty
acid
oxidation
fuel
ATP
synthesis,
oxidative
injury
resulting
increased
ROS
production
antioxidant
capacity,
enhanced
fission
defective
fusion,
impaired
mitophagy,
blunted
biogenesis
are
major
signatures
pathologies
during
cardiomyopathy.
This
review
alterations
underlying
abnormalities
associated
with
hyperglycemia
discusses
their
influence
on
cardiomyocyte
viability
function.
Based
basic
research
findings
clinical
evidence,
treatment
standards
impact
function,
well
mitochondria-targeted
therapies
potential
benefit
patients,
also
summarized.